Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Fuji
McKesson
Accenture
AstraZeneca
Farmers Insurance

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 7,494,654

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,494,654
Title:Compositions and methods for treating cardiovascular conditions with botulinum toxin
Abstract: The present invention provides for methods of treating cardiovascular diseases in a mammal. The methods include a step of administering an effective amount of a botulinum toxin directly to a blood vessel of a mammal thereby treating a cardiovascular disease.
Inventor(s): Brooks; Gregory F. (Irvine, CA), Donovan; Stephen (Capistrano Beach, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:10/870,603
Patent Claims:see list of patent claims

Details for Patent 7,494,654

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Elan Pharm MYOBLOC botulinum toxin type b VIAL 103846 001 2000-12-08   Try a Free Trial Allergan, Inc. (Irvine, CA) 2019-08-10 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Argus Health
US Department of Justice
Julphar
Moodys
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.